0001209191-24-001195.txt : 20240108 0001209191-24-001195.hdr.sgml : 20240108 20240108184824 ACCESSION NUMBER: 0001209191-24-001195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Janssen Robert CENTRAL INDEX KEY: 0001580849 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 24521395 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES STREET 2: 2929 SEVENTH STREET, SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-04 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001580849 Janssen Robert C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720 EMERYVILLE CA 94608 0 1 0 0 SVP and CMO 1 Common Stock 2024-01-04 4 M 0 1500 9.41 A 51425 D Common Stock 2024-01-04 4 S 0 1500 15.00 D 49925 D Stock Option (Right to Buy) 9.41 2024-01-04 4 M 0 1500 D 2028-02-02 Common Stock 1500 38673 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 14, 2023. This option grant will vest over three (3) years with one-third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 3, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter. Not applicable. /s/ Robert Janssen 2024-01-08